Petty George W, Khandheria Buoy K, Whisnant Jack P, Sicks JoRean D, O'Fallon W Michael, Wiebers David O
Section of Cerebrovascular/Critical Care, Mayo Clinic College of Medicine, 200 First St SW, Rochester, MN 55905, USA.
Mayo Clin Proc. 2005 Aug;80(8):1001-8. doi: 10.4065/80.8.1001.
To estimate the rates and predictors of survival and recurrence among residents of Olmsted County, Minnesota, who received an Initial diagnosis based on 2-dimensional color Doppler echocardiography of moderate or severe mitral or aortic stenosis or regurgitation and who experienced a first ischemic stroke, transient ischemic attack (TIA), or amaurosis fugax.
At the Mayo Clinic in Rochester, Minn, we used the resources of the Rochester Epidemiology Project to identify Individuals who met the criteria for inclusion in the study and to verify exclusion criteria. The study included all residents of Olmsted County, Minnesota, who experienced a first Ischemic stroke, TIA, or amaurosis fugax within 30 days of or subsequent to receiving a first-time 2-dimensional color Doppler echocardlography-based diagnosis of moderate or severe mitral or aortic stenosis or regurgitation between January 1, 1985, and December 31, 1992. The Kaplan-Meier product-limit method was used to estimate the rates of subsequent stroke and death after the ischemic stroke, TIA, or amaurosis fugax. The Cox proportional hazards model was used to assess the effect of several potential risk factors on subsequent stroke occurrence and death.
For the 125 patients in the study, the Kaplan-Meier estimates of the risk of death and the risk of stroke at 2-year follow-up were 38.6% (95% confidence interval [CI], 29.9%-47.5%) and 18.5% (95% CI, 10.0%-27.0%), respectively. Compared with the general population, death rates were significantly Increased (standardized mortality ratio = 1.75; 95% CI, 1.38-2.19; P < .001) but rates of subsequent stroke occurrence were not (standardized morbidity ratio = 1.20; 95% CI, 0.75-1.84; P = .40). After adjustment for age, sex, and cardiac comorbidity, neither the type nor severity of valvular heart disease was an independent determinant of survival or subsequent stroke occurrence.
Patients with mitral or aortic valvular heart disease who experience Ischemic stroke, TIA, or amaurosis fugax have Increased rates of death, but not recurrent stroke, compared with expected rates. Other cardiovascular risk factors are more important determinants of survival In these patients than the type or echocardiographic severity of the valvular heart disease.
评估明尼苏达州奥尔姆斯特德县居民中,那些基于二维彩色多普勒超声心动图首次诊断为中度或重度二尖瓣或主动脉瓣狭窄或反流,且首次发生缺血性卒中、短暂性脑缺血发作(TIA)或一过性黑矇的患者的生存率及复发率,并确定相关预测因素。
在明尼苏达州罗切斯特市的梅奥诊所,我们利用罗切斯特流行病学项目的资源来确定符合研究纳入标准的个体,并核实排除标准。该研究纳入了1985年1月1日至1992年12月31日期间,在首次基于二维彩色多普勒超声心动图诊断为中度或重度二尖瓣或主动脉瓣狭窄或反流后的30天内或之后首次发生缺血性卒中、TIA或一过性黑矇的明尼苏达州奥尔姆斯特德县所有居民。采用Kaplan-Meier乘积限界法来估计缺血性卒中、TIA或一过性黑矇后后续卒中及死亡的发生率。使用Cox比例风险模型来评估多个潜在风险因素对后续卒中发生及死亡的影响。
对于研究中的125例患者,2年随访时Kaplan-Meier法估计的死亡风险和卒中风险分别为38.6%(95%置信区间[CI],29.9%-47.5%)和18.5%(95%CI,10.0%-27.0%)。与普通人群相比,死亡率显著升高(标准化死亡比=1.75;95%CI,1.38-2.19;P<.001),但后续卒中发生率未升高(标准化发病比=1.20;95%CI,0.75-1.84;P=.40)。在对年龄、性别和心脏合并症进行校正后,瓣膜性心脏病的类型和严重程度均不是生存或后续卒中发生的独立决定因素。
与预期发生率相比,患有二尖瓣或主动脉瓣瓣膜性心脏病且发生缺血性卒中、TIA或一过性黑矇的患者死亡率升高,但卒中复发率未升高。在这些患者中,其他心血管危险因素比瓣膜性心脏病的类型或超声心动图严重程度更能决定生存情况。